Borussia Dortmund GmbH & Co. KGaA / Key word(s): Change of Personnel 11.08.2014 09:40 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- The Executive Committee of the Advisory Board of Borussia Dortmund Geschäftsführungs-GmbH has prematurely renewed the employment contract of the CEO Hans-Joachim Watzke. The employment contract that was due to expire on December 31st, 2016 was extended now until December 31st, 2019. Hans-Joachim Watzke remains as hitherto chief executive officer (CEO) of Borussia Dortmund Geschäftsführungs-GmbH and primarily responsible for companys' strategy and the business divisions "sports", "communication" and "sponsoring". He is exempted from the restrictions of § 181 BGB (German Civil Code). Dortmund, 11th August 2014 Borussia Dortmund GmbH & Co. KGaA Borussia Dortmund Geschäftsführungs-GmbH 11.08.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Borussia Dortmund GmbH & Co. KGaA Rheinlanddamm 207 - 209 44137 Dortmund Germany Phone: 0231/ 90 20 - 2746 Fax: 0231/ 90 20 - 852746 E-mail: aktie@bvb.de Internet: www.bvb.de/aktie // www.aktie.bvb.de ISIN: DE0005493092 WKN: 549309 Indices: SDAX Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Employment contract of CEO Hans-Joachim Watzke
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Investigating Manitex International: A Closer Look at MNTX
Examining Fair Treatment for Manitex International Shareholders Ademi LLP has launched an investigation into Manitex International, Inc. (NASDAQ: MNTX) due to concerns about possible breaches of fiduciary duty related to its recent transaction with Tadano. This investigation raises important questions about whether shareholders are being treated fairly in the financial...
Continue Reading
MediDrive Launches Innovative Transportation Management System
MediDrive Unveils a New Era in Healthcare Transportation MediDrive, a key player in the Non-Emergency Medical Transportation (NEMT) field, has launched a groundbreaking Transportation Management System (TMS). This new system aims to simplify how healthcare organizations manage patient transportation, enabling health plans, hospitals, and physicians to efficiently meet...
Continue Reading
US Labor Market Faces Stagnation Challenges Amid Caution Calls
US Labor Market Could Face Unprecedented Stagnation The U.S. labor market is on the brink of facing a significant stagnation, as warned by David Kelly, chief global strategist at JPMorgan Asset Management. He forecasts a troubling period where worker growth may come to a standstill over the next five years. This insight reflects a critical moment for the economy as...
Continue Reading
Fifth Third’s Newline™ Recognized as Top Embedded Finance Solution
Newline™ by Fifth Third Receives Prestigious Award Newline™ by Fifth Third has recently been celebrated as the Best New Embedded Finance Platform at the Big Bank Theory Awards, organized by Tearsheet. This award showcases the innovation and leadership present in the financial technology sector, particularly highlighting how companies are transforming the banking...
Continue Reading
Moore Law, PLLC Investigates Amgen Inc. Tax Liability Claims
Moore Law, PLLC Launches Investigation into Amgen Inc. Moore Law, PLLC is a prominent securities and shareholder law firm situated on Wall Street, and they are currently investigating potential claims relevant to Amgen Inc. (NASDAQ: AMGN). The law firm is focused on protecting investors who may have been affected by recent legal developments surrounding the pharmaceutical...
Continue Reading